{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:51:44Z","timestamp":1787169104257,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.semarthrit.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T22:18:47Z","timestamp":1434579527000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort"],"prefix":"10.1016","volume":"45","author":[{"given":"Gerd Cecilie","family":"Dobloug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torhild","family":"Garen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine","family":"Brunborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Tore","family":"Gran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.06.005_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.berh.2004.02.009","article-title":"Adult inflammatory myopathies","volume":"18","author":"Christopher-Stine","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality of polymyositis and dermatomyositis patients","volume":"25","author":"Airio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib4","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","article-title":"Morbidity and mortality in adult polymyositis and dermatomyositis","volume":"14","author":"Marie","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"Pt 11","key":"10.1016\/j.semarthrit.2015.06.005_bib6","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib7","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00415-009-5229-9","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox","year":"2009","journal-title":"J Neurol"},{"issue":"Pt 11","key":"10.1016\/j.semarthrit.2015.06.005_bib8","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12016-013-8387-6","article-title":"The evolving spectrum of polymyositis and dermatomyositis-moving towards clinicoserological syndromes: a critical review","volume":"47","author":"Tansley","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.semarthrit.2015.06.005_bib12","article-title":"Progress report on the Development of classification criteria for adult and juvenile idiopathic inflammatory myopathies","volume":"12","author":"C","year":"2014","journal-title":"Pediat Rheum."},{"key":"10.1016\/j.semarthrit.2015.06.005_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib17","series-title":"Inclusion body myositis","author":"Verschuuren","year":"1997"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib18","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC International Workshop: inclusion body myositis, 2\u20134 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/89.4.747","article-title":"Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis","volume":"89","author":"Rose","year":"1966","journal-title":"Brain"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib20","first-page":"207","article-title":"Survival in polymyositis: corticosteroids and risk factors","volume":"4","author":"Carpenter","year":"1977","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","article-title":"Factors affecting survivorship in polymyositis. A life-table study of 124 patients","volume":"14","author":"Medsger","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib22","first-page":"263","article-title":"Long-term prognosis of 69 patients with dermatomyositis or polymyositis","volume":"14","author":"Maugars","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0049-0172(86)90014-4","article-title":"Adult onset polymyositis\/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature","volume":"15","author":"Hochberg","year":"1986","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"Sultan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib25","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar3704","article-title":"Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine","volume":"14","author":"Schiopu","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib28","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","article-title":"Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan","volume":"38","author":"Yamasaki","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08916930600622603","article-title":"Survival, mortality and causes of death in inflammatory myopathies","volume":"39","author":"Torres","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib31","article-title":"Assessment of mortality in sporadic inclusion body myositis; a Delphi Panel Technique (P1.025)","volume":"82","author":"Barghout","year":"2014","journal-title":"Gen Neurol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib32","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10067-011-1840-0","article-title":"Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases","volume":"30","author":"Yu","year":"2011","journal-title":"Clin Rheumato"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.2009.03216.x","article-title":"Defining cancer risk in dermatomyositis. part I","volume":"34","author":"Madan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4103\/1947-2714.120788","article-title":"Malignancy and idiopathic inflammatory myopathies","volume":"5","author":"Ungprasert","year":"2013","journal-title":"North Am J Med Sci"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2230.2009.03227.x","article-title":"Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology","volume":"34","author":"Madan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib39","article-title":"Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort","author":"Dobloug","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12627","article-title":"High prevalence of inclusion body myositis in Norway; a population based clinical epidemiology study","volume":"22","author":"Dobloug","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.21895","article-title":"Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome","volume":"65","author":"Marie","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00455-011-9338-0","article-title":"Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence","volume":"27","author":"Mulcahy","year":"2012","journal-title":"Dysphagia"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib44","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","article-title":"Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome","volume":"24","author":"Marie","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.005_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2230.2009.03227.x","article-title":"Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology","volume":"34","author":"Madan","year":"2009","journal-title":"Clin Exp Dermatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T01:27:41Z","timestamp":1566869261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0049017215001432"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}